| Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer (NCT03567655) | Asan Medical Center | 2018-07-15 |
| Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer (NCT03115593) | Brugmann University Hospital | 2018-07-10 |
| Anxiety and Distress Levels in Women With Suspected Endometrial Cancer (NCT03813719) | Imperial College London | 2018-07-01 |
| Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium (NCT03476798) | University of Oklahoma | 2018-06-29 |
| POSE - POs Surgery Endometrial Cancer (NCT06394258) | Fundacao Champalimaud | 2018-06-18 |
| Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers (NCT03564340) | Regeneron Pharmaceuticals | 2018-05-21 |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451) | Corvus Pharmaceuticals, Inc. | 2018-04-25 |
| Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC (NCT03463252) | West China Second University Hospital | 2018-04-01 |
| Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer (NCT03503786) | National Cancer Institute, Naples | 2018-04-01 |
| Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer (NCT03466788) | Centre Francois Baclesse | 2018-03-29 |
| FPA150 in Patients With Advanced Solid Tumors (NCT03514121) | Five Prime Therapeutics, Inc. | 2018-03-27 |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma (NCT03395080) | Leap Therapeutics, Inc. | 2018-03-05 |
| A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients (NCT03285152) | Memorial Sloan Kettering Cancer Center | 2018-02-19 |
| The Role of Hypoxia as a Selective Pressure for TP53 Mutations (NCT03466034) | Institute of Cancer Research, United Kingdom | 2018-02-06 |
| ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma (NCT03394027) | National Cancer Institute (NCI) | 2018-01-17 |
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] (NCT03555422) | Karyopharm Therapeutics Inc | 2018-01-05 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| Sentinel Node Mapping in High Risk Endometrial Cancer (NCT03366051) | AC Camargo Cancer Center | 2017-12-22 |
| Human Epididymis Protein 4 in Endometrial Carcinoma (NCT03456791) | Ain Shams University | 2017-12-01 |
| HE4 is a Beneficial Biomarker in Endometrial Cancer (NCT03459976) | Ain Shams University | 2017-12-01 |
| A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors (NCT03314935) | Incyte Corporation | 2017-11-21 |
| Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. (NCT03345485) | Mundipharma Research Limited | 2017-11-08 |
| Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer (NCT03016338) | University Health Network, Toronto | 2017-11-06 |
| Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing (NCT03322176) | Data Collection Analysis Business Management | 2017-10-17 |
| European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III (NCT04504006) | Dr. Paul Buderath | 2017-10-10 |
| Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer (NCT03189446) | University of Oklahoma | 2017-10-02 |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers (NCT03212404) | Checkpoint Therapeutics, Inc. | 2017-09-20 |
| Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors (NCT03170960) | Exelixis | 2017-09-05 |
| Pembro/Carbo/Taxol in Endometrial Cancer (NCT02549209) | Daniela Matei, MD | 2017-08-22 |
| Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? (NCT03543215) | Imperial College London | 2017-07-13 |
| Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients (NCT03210129) | Luxembourg Institute of Health | 2017-07-06 |
| Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer (NCT03192059) | University Hospital, Ghent | 2017-07-01 |
| An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer (NCT03077698) | Xenetic Biosciences, Inc. | 2017-06-14 |
| Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? (NCT03207126) | Imperial College London | 2017-06-13 |
| Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? (NCT03207061) | Imperial College London | 2017-06-13 |
| Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? (NCT03207074) | Imperial College London | 2017-06-13 |
| Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer (NCT03099499) | Fox Chase Cancer Center | 2017-06-08 |
| Effectiveness of Care in Certified Cancer Centres in Germany (NCT04334239) | Technische Universität Dresden | 2017-05-01 |
| Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC) (NCT02566811) | University College, London | 2017-04-12 |
| Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer (NCT04302714) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-03-20 |
| Scale Down for Endometrial Cancer (NCT03169023) | Washington University School of Medicine | 2017-02-21 |
| Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer (NCT02730429) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2017-02-15 |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer (NCT03015129) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
| Carboplatin-cyclophosphamide Combined With Atezolizumab (NCT02914470) | The Netherlands Cancer Institute | 2017-01-01 |
| Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer (NCT02730416) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2016-12-12 |
| A Study to Assess the Efficacy and Safety of ABTL0812 (NCT03366480) | Ability Pharmaceuticals SL | 2016-12-01 |
| Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors (NCT02988817) | Genmab | 2016-11-23 |
| A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer (NCT02922764) | Inspirna, Inc. | 2016-11-01 |
| Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer (NCT02943811) | Università degli Studi dell'Insubria | 2016-10-01 |
| Positron Emission Tomography (PET) Imaging Studies With NIS Reporter (NCT02907073) | Mayo Clinic | 2016-09-01 |
| Endometrial Cancer Biomarker Changes Following Exposure to Metformin (NCT02042495) | Jewish General Hospital | 2016-08-01 |
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life (NCT03000192) | University Hospital Southampton NHS Foundation Trust | 2016-08-01 |
| Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (NCT02834988) | University of Miami | 2016-07-28 |
| Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer (NCT02912767) | Memorial Sloan Kettering Cancer Center | 2016-07-20 |
| A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus (NCT02744898) | NYU Langone Health | 2016-07-01 |
| Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers (NCT02725489) | Mary Crowley Medical Research Center | 2016-06-03 |
| Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding (NCT03330015) | Chinese University of Hong Kong | 2016-06-03 |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
| Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer (NCT02765698) | Mayo Clinic | 2016-05-01 |
| MR-HIFU for Recurrent Gynaecological Cancer (NCT02714621) | Institute of Cancer Research, United Kingdom | 2016-05-01 |
| Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine (NCT02774395) | Centre Hospitalier Universitaire de Nice | 2016-05-01 |
| Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers (NCT02638402) | National Taiwan University Hospital | 2016-05-01 |
| Guangzhou Women's Health Cohort Study (GWHCS) (NCT05506800) | Guangzhou Women and Children's Medical Center | 2016-03-03 |
| SLNM in Endometrial Cancer Combined With OSNA (NCT02826291) | Charles University, Czech Republic | 2016-03-01 |
| Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer (NCT02990728) | Chang Gung Memorial Hospital | 2016-03-01 |
| MK-3475 Immunotherapy in Endometrial Carcinoma (NCT02630823) | Washington University School of Medicine | 2016-02-05 |
| Intraoperative Examination of Sentinel Node in Endometrial Cancer (TRSGO-SLN-003) (NCT04560491) | Ankara University | 2016-02-01 |
| Advanced Methods for Cancer Detection by Vaginal Screening (NCT02622776) | Anna Tinker | 2016-02-01 |
| Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation (NCT02658565) | Frederick R. Ueland, M.D. | 2016-01-29 |
| Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors (NCT02646748) | Incyte Corporation | 2016-01-25 |
| Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer (NCT02987777) | Institut de Cancérologie de Lorraine | 2016-01-01 |
| Cancer of the Uterus and Treatment of Stress Urinary Incontinence (NCT02667431) | Women and Infants Hospital of Rhode Island | 2016-01-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping (NCT02209532) | Novadaq Technologies ULC, now a part of Stryker | 2015-12-01 |
| Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies (NCT02433626) | Critical Outcome Technologies Inc. | 2015-12-01 |
| Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification (NCT03171506) | University of Alabama at Birmingham | 2015-11-09 |
| Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium (NCT02589366) | University of California, San Diego | 2015-11-01 |
| Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) (NCT02558348) | Advenchen Laboratories, LLC | 2015-11-01 |
| A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium (NCT02767362) | UNC Lineberger Comprehensive Cancer Center | 2015-11-01 |
| Biomarker Guided Treatment in Gynaecological Cancer (NCT02543710) | Haukeland University Hospital | 2015-10-01 |
| Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients (NCT02560571) | Meir Medical Center | 2015-10-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso (NCT02580747) | Chinese PLA General Hospital | 2015-10-01 |
| Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer (NCT05261165) | F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica | 2015-10-01 |
| Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY (NCT02762214) | Catholic University of the Sacred Heart | 2015-10-01 |
| Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive (NCT04290299) | National Cancer Institute, Naples | 2015-09-15 |
| Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer (NCT02549989) | Memorial Sloan Kettering Cancer Center | 2015-09-01 |
| ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More? (NCT02413606) | Comprehensive Cancer Centre The Netherlands | 2015-09-01 |
| Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors (NCT02684318) | Poveda, Andrés, M.D. | 2015-07-01 |
| Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer (NCT02665962) | Abramson Cancer Center at Penn Medicine | 2015-07-01 |
| Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole (NCT02476955) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2015-06-09 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| Translating Healthy Lifestyle Interventions for Cancer Survivors (NCT02690766) | University of North Carolina, Chapel Hill | 2015-03-01 |
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
| Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer (NCT02117817) | Rutgers, The State University of New Jersey | 2015-02-01 |
| Effect of Fertility-sparing Therapy of Early Endometrial Cancer (NCT03538704) | Peking University People's Hospital | 2015-01-01 |
| Exercise as an Intervention in Endometrial Cancer Survivors (NCT02367950) | Royal Cornwall Hospitals Trust | 2015-01-01 |
| Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer (NCT02285192) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers (NCT02269293) | Memorial Sloan Kettering Cancer Center | 2014-10-13 |
| Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors (NCT02262455) | Santa Maria Biotherapeutics | 2014-10-01 |
| 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial (NCT02320565) | Catholic University of the Sacred Heart | 2014-10-01 |